SG11201909747WA - Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole - Google Patents

Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole

Info

Publication number
SG11201909747WA
SG11201909747WA SG11201909747WA SG11201909747WA SG 11201909747W A SG11201909747W A SG 11201909747WA SG 11201909747W A SG11201909747W A SG 11201909747WA SG 11201909747W A SG11201909747W A SG 11201909747WA
Authority
SG
Singapore
Prior art keywords
hydroxybenzoyl
benzothiazole
dioxo
dichloro
dihydro
Prior art date
Application number
Other languages
English (en)
Inventor
Junichiro Uda
Seiichi Kobashi
Misa Hasegawa
Original Assignee
Fuji Yakuhin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Yakuhin Co Ltd filed Critical Fuji Yakuhin Co Ltd
Publication of SG11201909747WA publication Critical patent/SG11201909747WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
SG11201909747W 2017-04-28 2018-04-27 Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole SG11201909747WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017099334 2017-04-28
PCT/JP2018/017128 WO2018199277A1 (fr) 2017-04-28 2018-04-27 Forme cristalline et sel de 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole

Publications (1)

Publication Number Publication Date
SG11201909747WA true SG11201909747WA (en) 2019-11-28

Family

ID=63918527

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201909747W SG11201909747WA (en) 2017-04-28 2018-04-27 Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole

Country Status (20)

Country Link
US (1) US10752601B2 (fr)
EP (1) EP3617199B1 (fr)
JP (1) JP7132211B2 (fr)
KR (1) KR102597986B1 (fr)
CN (1) CN110914246B (fr)
AU (1) AU2018256993B9 (fr)
BR (1) BR112019018840B1 (fr)
CA (1) CA3055517A1 (fr)
ES (1) ES2958064T3 (fr)
HR (1) HRP20230829T1 (fr)
HU (1) HUE063661T2 (fr)
IL (1) IL269689B (fr)
MX (1) MX2019010710A (fr)
MY (1) MY185728A (fr)
PH (1) PH12019501982A1 (fr)
PL (1) PL3617199T3 (fr)
SG (1) SG11201909747WA (fr)
TW (1) TWI766986B (fr)
WO (1) WO2018199277A1 (fr)
ZA (1) ZA201905817B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7355846B2 (ja) * 2019-12-09 2023-10-03 株式会社富士薬品 固形製剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
US20080064871A1 (en) 2006-05-26 2008-03-13 Japan Tobacco Inc. Production Method of Nitrogen-Containing Fused Ring Compounds
US20080305169A1 (en) 2006-05-26 2008-12-11 Japan Tobacco Inc. Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds
GB0702458D0 (en) * 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
WO2009086303A2 (fr) 2007-12-21 2009-07-09 University Of Rochester Procédé permettant de modifier la durée de vie d'organismes eucaryotes
JP5325065B2 (ja) * 2009-09-30 2013-10-23 株式会社富士薬品 新規フェノール誘導体

Also Published As

Publication number Publication date
MX2019010710A (es) 2019-12-18
EP3617199A1 (fr) 2020-03-04
IL269689A (fr) 2019-11-28
US20190389818A1 (en) 2019-12-26
BR112019018840A2 (pt) 2020-04-14
ES2958064T3 (es) 2024-01-31
AU2018256993B2 (en) 2021-12-02
EP3617199A9 (fr) 2021-03-17
MY185728A (en) 2021-06-01
KR102597986B1 (ko) 2023-11-02
CN110914246B (zh) 2023-03-10
WO2018199277A1 (fr) 2018-11-01
PL3617199T3 (pl) 2024-01-22
HUE063661T2 (hu) 2024-01-28
PH12019501982A1 (en) 2020-12-07
AU2018256993B9 (en) 2023-06-22
CN110914246A (zh) 2020-03-24
TW201843145A (zh) 2018-12-16
ZA201905817B (en) 2021-05-26
RU2019130977A3 (fr) 2021-07-01
BR112019018840B1 (pt) 2023-12-19
US10752601B2 (en) 2020-08-25
TWI766986B (zh) 2022-06-11
JPWO2018199277A1 (ja) 2020-03-12
EP3617199B1 (fr) 2023-07-26
AU2018256993A1 (en) 2019-10-10
KR20200002847A (ko) 2020-01-08
IL269689B (en) 2022-07-01
EP3617199C0 (fr) 2023-07-26
EP3617199A4 (fr) 2020-11-18
RU2019130977A (ru) 2021-05-28
HRP20230829T1 (hr) 2023-11-10
JP7132211B2 (ja) 2022-09-06
CA3055517A1 (fr) 2018-11-01

Similar Documents

Publication Publication Date Title
ZA202001340B (en) Heterocyclic compound and use thereof
SG11201706908PA (en) 1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
IL283486A (en) Thiazole derivatives kill microorganisms
LT3464284T (lt) Mikrobiocidiniai tiazolo dariniai
IL274887A (en) Thiazole derivatives kill microorganisms
ZA202004532B (en) Compositions for the management of hyperglycemia and related conditions
IL265298B (en) History of 5-[2-(pyridin-2-ylamino)-3,1-thiazol-5-yl]-3,2,dihydro-1 h -isoindol-1-one and their use as dual inhibitors of phosphatidylinositol 3-kinase delta and gamma
ZA201801089B (en) N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3] thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl] amides
IL279939A (en) History of thiadiazine
IL273237A (en) Novel heterocyclic compounds as MGLUR7 modulators
SG11202110615TA (en) Heterocyclic compounds and uses thereof
PL3733177T3 (pl) Kompozycja do ochrony rogówki
IL272121A (en) Preparation and methods for the treatment of myopia
ZA201905817B (en) Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole
PL3694843T3 (pl) Nowa sól i nowe stałe postacie escitalopramu
EP3661505A4 (fr) Benzothiazoles et composés connexes
GB201707207D0 (en) Treatment of type 1 diabetes
ZA202002526B (en) New alcoxyamino derivatives for treating pain and pain related conditions
LT3212644T (lt) 2-(1,2,4-triazol-3-ilsulfanil)-n-1,3,4-tiadiazol-2-ilacetamido dariniai, kurie yra naudotini diabeto gydymui
SG11201708692WA (en) Salt form, crystal form and intermediate of 1,2,5-thiadiazolidine-1,1-dioxide and preparation method thereof
ZA202000399B (en) Heterocyclylmethylidene derivatives and their use as modulators of mglur5 receptors
HUP1700154A2 (en) Use of nicosulfuron and clomazone on fabales/fabaceae
GB201610823D0 (en) Heterocyclic compounds and medical uses
ME03518B (fr) Combinaisons comprenant des modulateurs allostériques positifs de sous-type 2 de récepteurs glutamatergiques métabotropes et leur utilisation